The global immunomodulators market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America holds the largest share of the market due to the presence of a large number of pharmaceutical companies and a high prevalence of diseases that require immunomodulatory treatment. Europe is the second-largest Immunomodulators Market due to the presence of a well-established healthcare infrastructure and a high demand for personalized medicine. The Asia-Pacific region is expected to witness the highest growth during the forecast period due to the increasing prevalence of diseases and a growing demand for advanced healthcare facilities. The increasing geriatric population is also driving the growth of the immunomodulators market. As people age, their immune systems become weaker, making them more susceptible to infections, autoimmune diseases, and cancer.
Read more @ https://creativeedge16.blogspot.com/2023/02/immunomodulators-market-trend-forecast.html
